These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1551174)

  • 1. Ionic rhenocene derivatives with antitumor activity.
    Köpf-Maier P; Klapötke T
    Cancer Chemother Pharmacol; 1992; 29(5):361-6. PubMed ID: 1551174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.
    Köpf-Maier P; Klapötke T
    J Cancer Res Clin Oncol; 1992; 118(3):216-21. PubMed ID: 1548287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic titanocene complexes: a new type of antitumor agent.
    Köpf-Maier P; Neuse E; Klapötke T; Köpf H
    Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of titanocene amino acid complexes.
    Köpf-Maier P; Tornieporth-Oetting IC
    Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor properties of organometallic metallocene complexes of tin and germanium.
    Köpf-Maier P; Janiak C; Schumann H
    J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
    Natorkhin MI; Stukov AN; Filov VA
    Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P; Köpf H
    Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors.
    Köpf-Maier P; Klapötke T
    Arzneimittelforschung; 1989 Mar; 39(3):369-71. PubMed ID: 2757661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
    Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
    Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
    Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
    J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of rhenium carboxylates as antitumor agents. Part II. Antitumor studies of bis (mu-propionato) diaquotetrabromodirhenium (III) in tumor-bearing mice.
    Eastland GW; Yang G; Thompson T
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):435-8. PubMed ID: 6668962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molybdocene dichloride as an antitumor agent (author's transl)].
    Köpf-Maier P; Leitner M; Voigtländer R; Köpf H
    Z Naturforsch C Biosci; 1979 Dec; 34(12):1174-6. PubMed ID: 161840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].
    Köpf-Maier P; Hesse B; Köpf H
    J Cancer Res Clin Oncol; 1980 Jan; 96(1):43-51. PubMed ID: 7188941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Bara A; Socaciu C; Silvestru C; Haiduc I
    Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C; Socaciu C; Bara A; Haiduc I
    Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferricenium complexes: a new type of water-soluble antitumor agent.
    Köpf-Maier P; Köpf H; Neuse EW
    J Cancer Res Clin Oncol; 1984; 108(3):336-40. PubMed ID: 6511806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
    Köpf-Maier P; Moormann A; Köpf H
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.
    Köpf-Maier P; Klapötke T
    Arzneimittelforschung; 1989 Apr; 39(4):488-90. PubMed ID: 2751735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of ferratricarbadecaboranyl complexes in murine and human tissue cultured cell lines.
    Hall IH; Warren AE; Lee CC; Wasczcak MD; Sneddon LG
    Anticancer Res; 1998; 18(2A):951-62. PubMed ID: 9615746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.